EXPRESSION OF COMPLEMENT ALTERNATIVE PATHWAY PROTEINS BY ENDOTHELIAL-CELLS - DIFFERENTIAL REGULATION BY INTERLEUKIN-1 AND GLUCOCORTICOIDS

被引:60
作者
DAUCHEL, H
JULEN, N
LEMERCIER, C
DAVEAU, M
OZANNE, D
FONTAINE, M
RIPOCHE, J
机构
[1] Inserm U-78, Bois-Guillaume
关键词
D O I
10.1002/eji.1830200808
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We have studied the secretion of proteins of the alternative pathway of complement C3, factor B and factor H by human umbilical vein endothelial cells (HUVEC). Results showed that factor H and factor B are quantitatively secreted in abundance whereas C3 could only be detected when the cells are maintained in culture during long periods of time. Interferon‐γ stimulated factor H, factor B and, to a lesser extent, C3 secretions. Interleukin (IL) 1 had a differential effect on spontaneous C3, factor B and factor H secretions. In the presence of IL 1, there was a significant secretion of C3 occurring within a short period of culture. IL 1 also stimulated factor B secretion. There was a synergistic stimulating effect between IL 1 and interferon‐γ to bring C3 and factor B productions by HUVEC to very high levels. In contrast, factor H secretion was consistently inhibited by IL 1. Local increase in C3 and factor B secretions by endothelial cells in the presence of IL 1 may have important implications in the inflammatory reaction. In striking contrast, the glucocorticoid dexamethasone (DXM) had modulatory effects which are consistent with its anti‐inflammatory properties. DXM, at therapeutic concentrations, decreased C3 and factor B secretions and increased factor H secretion. Local modulation of complement protein secretion by DXM appears to be a new mechanism by which this glucocorticoid may control inflammation. Copyright © 1990 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim
引用
收藏
页码:1669 / 1675
页数:7
相关论文
共 37 条
  • [1] PURIFICATION OF COMPLEMENT COMPONENTS BY HYDROPHOBIC AFFINITY-CHROMATOGRAPHY ON PHENYL SEPHAROSE - PURIFICATION OF HUMAN C5
    ALSALIHI, A
    RIPOCHE, J
    PRUVOST, L
    FONTAINE, M
    [J]. FEBS LETTERS, 1982, 150 (01): : 238 - 242
  • [2] AVRAMEAS S, 1977, TECHNIQUES IMMUNOFLU, P153
  • [3] BRANDSLUND I, 1988, COMPLEMENT, V5, P210
  • [4] BROOIMANS RA, 1989, J IMMUNOL, V142, P2024
  • [5] INTERLEUKIN-1 STIMULATES PLATELET-ACTIVATING-FACTOR PRODUCTION IN CULTURED HUMAN-ENDOTHELIAL CELLS
    BUSSOLINO, F
    BREVIARIO, F
    TETTA, C
    AGLIETTA, M
    MANTOVANI, A
    DEJANA, E
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1986, 77 (06) : 2027 - 2033
  • [6] ISOLATION OF BIOLOGICALLY-ACTIVE RIBONUCLEIC-ACID FROM SOURCES ENRICHED IN RIBONUCLEASE
    CHIRGWIN, JM
    PRZYBYLA, AE
    MACDONALD, RJ
    RUTTER, WJ
    [J]. BIOCHEMISTRY, 1979, 18 (24) : 5294 - 5299
  • [7] FACTOR B POLYMORPHISM - ANALYSIS BY ISOELECTRIC-FOCUSING IN IMMOBILIZED PH GRADIENTS FOLLOWED BY IMMUNOBLOTTING
    DAVRINCHE, C
    CHARLIONET, R
    RIVAT, C
    [J]. ELECTROPHORESIS, 1985, 6 (11) : 556 - 559
  • [8] DEBRUIJN MHL, 1985, P NATL ACAD SCI USA, V82, P708
  • [9] DINARELLO CA, 1984, NEW ENGL J MED, V311, P1413
  • [10] FALUS A, 1987, J IMMUNOL, V138, P856